A phase II study of capecitabine and lapatinib in advanced refractory colorectal adenocarcinoma: A Wisconsin Oncology Network study.
Frank D, Jumonville A, Loconte NK, Schelman WR, Mulkerin D, Lubner S, Richter K, Winterle N, Wims MB, Dietrich L, Winkler JM, Volk M, Kim K, Holen KD.
Frank D, et al. Among authors: loconte nk.
J Gastrointest Oncol. 2012 Jun;3(2):90-6. doi: 10.3978/j.issn.2078-6891.2011.049.
J Gastrointest Oncol. 2012.
PMID: 22811876
Free PMC article.